Oxygen Healthcare, operating under the name HomeDoc Technologies Baltic, is a pioneering startup focused on developing advanced medical technologies. The company is currently engaged in a significant project co-financed by the European Union, specifically through the European Regional Development Fund. This project is part of the EU's broader response to the COVID-19 pandemic and aims to enhance innovation in the healthcare sector.

The core objective of the project is to create a technology prototype that will facilitate the development of medical devices designed for the effective diagnosis of COVID-19. This involves extensive research and experimental development, leveraging large data analysis to improve diagnostic accuracy and efficiency. The total project budget is €1,023,604.50, with €818,883.60 funded by the European Regional Development Fund and the remainder covered by the company's own resources. The project is expected to be completed by the end of 2021.

Oxygen Healthcare serves a diverse range of clients, including healthcare providers, research institutions, and potentially government health agencies. The company operates in the healthcare technology market, which is rapidly growing due to increased demand for innovative solutions in medical diagnostics and treatment.

The business model of Oxygen Healthcare revolves around research and development (R&D) and the commercialization of its technological innovations. By developing cutting-edge medical devices, the company aims to generate revenue through product sales, licensing agreements, and potentially government contracts. The focus on COVID-19 related technologies positions the company to meet urgent global healthcare needs, thereby creating a strong market demand for its products.

In summary, Oxygen Healthcare is a forward-thinking startup dedicated to advancing medical technology for better healthcare outcomes, particularly in the context of the COVID-19 pandemic.

Keywords: medical technology, COVID-19 diagnosis, healthcare innovation, data analysis, EU-funded, R&D, medical devices, healthcare providers, diagnostics, startup.